Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

Cristina Olteanu, Alon Scope, Yael Steinberg-Silman, Michael Ziv, Neil H. Shear, Roni P. Dodiuk-Gad, Gal Markel

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)e139-e141
JournalInternational Journal of Dermatology
Issue number5
StatePublished - 1 May 2020
Externally publishedYes

Bibliographical note

Funding Information:
source: Dr. Gal Markel has the following supports that did not play any role in this manuscript: Advisory: MSD, BMS, Novartis, Biond biologics. Honoraria: MSD, BMS, Novartis, Roche, Medison. Research grants: Novartis, H&S Ventures. IP: Famewave, 4c biomed. Stocks/options: Famewave, 4c biomed, Biond biologics.

Cite this